Studies have shown that blocking the PI3K/Akt/mTOR signaling pathway can reduce the adhesion and migration abilities of HSCs, inhibit their proliferation, and reduce the synthesis of ECM collagen, thereby affecting the development of liver fibrosis [24, 25]. Here, AKT1 is linked to Hepatic fibrosis.